The health system said that a portion of N95 masks it bought between November and January were tested and found to be ineffective.
“We were recently notified by a manufacturer that potential counterfeit N95 masks were in a small portion of our supply. We took immediate steps to remove these masks from our sites and have replaced them with approved supplies,” a spokesperson for Cleveland Clinic told WKYC.
The spokesperson added that the masks were fraudulently branded and purchased through a third-party vendor. The health system said it has reached out to law enforcement.
Read the full article here.
More articles on supply chain:
Georgia suspends vaccine shipments to practice that offered shots to teachers
N95 mask demand will remain high this year, 3M CEO predicts
House investigates HHS ventilator deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
